Flu season is fast approaching, and with rising COVID-19 cases and RSV cases rising in the Southeast, public health officials are urging the public to prepare to head off what some worry could be a “tripledemic.”
Fortunately, vaccines are available for all three viruses.
About two-thirds of Americans plan to get the annual flu shot, according to pharmacy chain CVS.
And similar to the treatments for COVID-19, RSV — or respiratory syncytial virus — can be treated with monoclonal antibodies, which the Centers for Disease Control and Prevention expect to be ready by early October.
Furthermore, two new vaccines created by GSK and Pfizer “are available to protect older adults from severe RSV disease,” the CDC said.
And the newest COVID-19 vaccine boosters are expected to roll out this month, possibly as soon as next week.
For more information about the viruses, vaccines and treatments, visit the Johns Hopkins Bloomberg School of Public Health website.
